Tumor and microenvironment modification during progression of murine orthotopic bladder cancer

Clinical and Developmental Immunology

Volumn 2011, Issue , 2011, Pages

  Tham, Sin Mun ^a   Ng, Kee Hui ^a   Pook, Sim Hwee ^a   Esuvaranathan, Kesavan ^a   Mahendran, Ratha ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CXCL11 CHEMOKINE; CYCLOOXYGENASE 2; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANZYME B; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 12P35; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 6; MACROPHAGE DERIVED CHEMOKINE; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; TUMOR NECROSIS FACTOR ALPHA; PROSTATE SPECIFIC ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLADDER CANCER; CANCER GROWTH; CANCER TRANSPLANTATION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; MOUSE; NONHUMAN; ORTHOTOPIC TRANSPLANTATION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR MICROENVIRONMENT; ANIMAL; BLADDER; BLADDER TUMOR; C3H MOUSE; C57BL MOUSE; CARCINOMA; DISEASE COURSE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOLOGY; IMMUNOMODULATION; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; TH1 TH2 BALANCE; TRANSGENE; TUMOR CELL LINE;

ANIMALS; CARCINOMA; CELL LINE, TUMOR; DISEASE PROGRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOMODULATION; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; NEOPLASM TRANSPLANTATION; PROSTATE-SPECIFIC ANTIGEN; TH1-TH2 BALANCE; TRANSGENES; TUMOR MICROENVIRONMENT; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

EID: 84855176536     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2011/865684     Document Type: Article

References (48)

1. O'Donnell M. A., Optimizing BCG therapy Urologic Oncology 2009 27 3 325 329
2. Herr H. W., Morales A., History of bacillus calmette-guerin and bladder cancer: an immunotherapy success story Journal of Urology 2008 179 1 53 56 (Pubitemid 350216725)
3. Chen F., Zhang G., Cao Y., Hessner M. J., See W. A., MB49 murine urothelial carcinoma: molecular and phenotypic comparison to human cell Llines as a model of the direct tumor response to bacillus calmette-guerin Journal of Urology 2009 182 6 2932 2937
4. Horiguchi Y., Larchian W. A., Kaplinsky R., Fair W. R., Heston W. D. W., Intravesical liposome-mediated interleukin-2 gene therapy in orthotopic murine bladder cancer model Gene Therapy 2000 7 10 844 851 (Pubitemid 30303581)
5. Shiau A. L., Lin C. Y., Tzai T. S., Wu C. L., Postoperative immuno-gene therapy of murine bladder tumor by in vivo administration of retroviruses expressing mouse interferon- Cancer Gene Therapy 2001 8 1 73 81
6. Zang Z., Mahendran R., Wu Q., Yong T., Esuvaranathan K., Non-viral tumor necrosis factor-alpha gene transfer decreases the incidence of orthotopic bladder tumors International Journal of Molecular Medicine 2004 14 4 713 717
7. Wu Q., Mahendran R., Esuvaranathan K., Nonviral cytokine gene therapy on an orthotopic bladder cancer model Clinical Cancer Research 2003 9 12 4522 4528 (Pubitemid 37248411)
8. Wu Q., Esuvaranathan K., Mahendran R., Monitoring the response of orthotopic bladder tumors to granulocyte macrophage colony-stimulating factor therapy using the prostate-specific antigen gene as a reporter Clinical Cancer Research 2004 10 20 6977 6984 (Pubitemid 39383049)
9. Chen L., Chen D., Block E., O'Donnell M., Kufe D. W., Clinton S. K., Eradication of murine bladder carcinoma by intratumor injection of a bicistronic adenoviral vector carrying cDNAs for the IL-12 heterodimer and its inhibition by the IL-12 p40 subunit homodimer The Journal of Immunology 1997 159 1 351 359 (Pubitemid 127493719)
10. Loskog A. S. I., Fransson M. E., Totterman T. T. H., AdCD40L gene therapy counteracts T regulatory cells and cures aggressive tumors in an orthotopic bladder cancer model Clinical Cancer Research 2005 11 24 8816 8821 (Pubitemid 43005933)
11. Hikosaka S., Hara I., Miyake H., Hara S., Kamidono S., Antitumor effect of simultaneous transfer of interleukin-12 and interleukin-18 genes and its mechanism in a mouse bladder cancer model International Journal of Urology 2004 11 8 647 652 (Pubitemid 39128567)
12. Buscarini M., Quek M. L., Gilliam-Hegarich S., Kasahara N., Bochner B., Adenoviral receptor expression of normal bladder and transitional cell carcinoma of the bladder Urologia Internationalis 2007 78 2 160 166 (Pubitemid 46242102)
13. Lawrencia C., Mahendran R., Esuvaranathan K., Transfection of urothelial cells using methyl- -cyclodextrin solubilized cholesterol and Dotap Gene Therapy 2001 8 10 760 768 (Pubitemid 32509789)
14. Harimoto K., Sugimura K., Lee C. R., Kuratsukuri K., Kishimoto T., In vivo gene transfer methods in the bladder without viral vectors British Journal of Urology 1998 81 6 870 874 (Pubitemid 28300618)
15. Yang A. S., Lattime E. C., Tumor-induced interleukin 10 suppresses the ability of splenic Dendritic Cells to stimulate CD4 and CD8 T-cell responses Cancer Research 2003 63 9 2150 2157 (Pubitemid 36538620)
16. Halak B. K., Maguire H. C., Lattime E. C., Tumor-induced interleukin-10 inhibits type 1 immune responses directed at a tumor antigen as well as a non-tumor antigen present at the tumor site Cancer Research 1999 59 4 911 917 (Pubitemid 29086748)
17. Ninalga C., Loskog A., Klevenfeldt M., Essand M., Ttterman T. H., CpG oligonucleotide therapy cures subcutaneous and orthotopic tumors and evokes protective immunity in murine bladder cancer Journal of Immunotherapy 2005 28 1 20 27 (Pubitemid 40075934)
18. Cai J. H., Deng S., Kumpf S. W., Lee P. A., Zagouras P., Ryan A., Gallagher D. S., Validation of rat reference genes for improved quantitative gene expression analysis using low density arrays BioTechniques 2007 42 4 503 511
19. Seow S. W., Rahmat J. N., Bay B. H., Lee Y. K., Mahendran R., Expression of chemokine/cytokine genes and immune cell recruitment following the instillation of Mycobacterium bovis, bacillus Calmette- Guérin or Lactobacillus rhamnosus strain GG in the healthy murine bladder Immunology 2008 124 3 419 427 (Pubitemid 351793475)
20. Summerhayes I. C., Franks L. M., Effects of donor age on neoplastic transformation of adult mouse bladder epithelium in vitro Journal of the National Cancer Institute 1979 62 4 1017 1023 (Pubitemid 9174372)
21. Loskog A., Ninalga C., Hedlund T., Alimohammadi M., Malmstrm P. U., Ttterman T. H., Optimization of the MB49 mouse bladder cancer model for adenoviral gene therapy Laboratory Animals 2005 39 4 384 393 (Pubitemid 41565459)
22. Deepak P., Kumar S., Acharya A., Gender variation in interleukin-13 production: a possible mechanism of differential in vivo growth of a T-cell lymphoma Scandinavian Journal of Immunology 2008 67 6 581 588 (Pubitemid 351677416)
23. Wang X., Colby J. K. L., Rengel R. C., Fischer S. M., Clinton S. K., Klein R. D., Overexpression of cyclooxygenase-2 (COX-2) in the mouse urinary bladder induces he expression of Immune- And cell proliferation-related genes Molecular Carcinogenesis 2009 48 1 1 13
24. Liakou C. I., Kamat A., Tang D. N., Chen H., Sun J., Troncoso P., Logothetis C., Sharma P., CTLA-4 blockade increases IFN -producing CD4+ICOS hi cells to shift the ratio of effector to regulatory T cells in cancer patients Proceedings of the National Academy of Sciences of the United States of America 2008 105 39 14987 14992
25. Sandes E. O., Faletti A. G., Riveros M. D., Vidal M. D. C., Gimenez L., Casabé A. R., Eijn A. M., Expression of inducible nitric oxide synthase in tumoral and non-tumoral epithelia from bladder cancer patients Nitric Oxidey 2005 12 1 39 45 (Pubitemid 41071408)
26. Marhaba R., Nazarenko I., Knfler D., Reich E., Voronov E., Vitacolonna M., Hildebrand D., Elter E., Apte R. N., Zller M., Opposing effects of fibrosarcoma cell-derived IL-1 and IL-1 on immune response induction International Journal of Cancer 2008 123 1 134 145 (Pubitemid 351705201)
27. Qin X. J., Shi H. Z., Deng J. M., Liang Q. L., Jiang J., Ye Z. J., CCL22 recruits CD4-positive CD25-positive regulatory T cells into malignant pleural effusion Clinical Cancer Research 2009 15 7 2231 2237
28. Obiri N. I., Husain S. R., Debinski W., Puri R. K., Interleukin 13 inhibits growth of human renal cell carcinoma cells ependently of the p140 interleukin 4 receptor chain Clinical Cancer Research 1996 2 10 1743 1749 (Pubitemid 26356360)
29. Sharma P., Shen Y., Wen S., Yamada S., Jungbluth A. A., Gnjatic S., Bajorin D. F., Reuter V. E., Herr H., Old L. J., Sato E., CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinoma Proceedings of the National Academy of Sciences of the United States of America 2007 104 10 3967 3972 (Pubitemid 47181562)
30. Seow S. W., Cai S., Rahmat J. N., Bay B. H., Lee Y. K., Chan Y. H., Mahendran R., Lactobacillus rhamnosus GG induces tumor regression in mice bearing orthotopic bladder tumors Cancer Science 2010 101 3 751 758
31. Sharma P., Shen Y., Wen S., Bajorin D. F., Reuter V. E., Old L. J., Jungbluth A. A., Cancer-testis antigens: expression and correlation with survival in human urothelial carcinoma Clinical Cancer Research 2006 12 18 5442 5447 (Pubitemid 44497259)
32. Chow L., Rezmann L., Imamura K., Wang L., Catt K., Tikellis C., Louis W. J., Frauman A. G., Louis S. N. S., Functional angiotensin II type 2 receptors inhibit growth factor signaling in LNCaP and PC3 prostate cancer cell lines Prostate 2008 68 6 651 660 (Pubitemid 351614643)
33. Kang K. H., Park S. Y., Rho S. B., Lee J. H., Tissue inhibitor of metalloproteinases-3 interacts with angiotensin II type 2 receptor and additively inhibits angiogenesis Cardiovascular Research 2008 79 1 150 160 (Pubitemid 351881938)
34. Walther T., Menrad A., Orzechowski H. D., Siemeister G., Paul M., Schirner M., Differential regulation of in vivo angiogenesis by angiotensin II receptors The FASEB Journal 2003 17 14 2061 2067 (Pubitemid 37392450)
35. Li H., Qi Y., Li C., Braseth L. N., Gao Y., Shabashvili A. E., Katovich M. J., Sumners C., Angiotensin type 2 receptor-mediated apoptosis of human prostate cancer cells Molecular Cancer Therapeutics 2009 8 12 3255 3265
36. Yamada H., Luo Y., Matsumoto T., O'Donnell M. A., A novel expression of macrophage derived chemokine in human bladder cancer Journal of Urology 2005 173 3 990 995 (Pubitemid 40239382)
37. Yang J., Richmond A., The angiostatic activity of interferon-inducible protein-10/CXCL10 in human melanoma depends on binding to CXCR3 but not to glycosaminoglycan Molecular Therapy 2004 9 6 846 855 (Pubitemid 38878130)
38. Loskog A., Ninalga C., Paul-Wetterberg G., de la Torre M., Malmstrm P. U., Ttterman T. H., Human bladder carcinoma is dominated by T-regulatory cells and Th1 inhibitory cytokines Journal of Urology 2007 177 1 353 358 (Pubitemid 44879486)
39. Kaashoek J. G. J., Mout R., Falkenburg J. H. F., Willemze R., Fibbe W. E., Landegent J. E., Cytokine production by the bladder carcinoma cell line 5637: rapid analysis of mRNA expression levels using a cDNA-PCR procedure Lymphokine and Cytokine Research 1991 10 3 231 235
40. Amann B., Perabo F. G. E., Wirger A., Hugenschmidt H., Schultze-Seemann W., Urinary levels of monocyte chemo-attractant protein-1 correlate with tumour stage and grade in patients with bladder cancer British Journal of Urology 1998 82 1 118 121 (Pubitemid 28316680)
41. Wolf H., Haeckel C., Roessner A., Inducible nitric oxide synthase expression in human urinary bladder cancer Virchows Archiv 2000 437 6 662 666 (Pubitemid 32003098)
42. Kang S., Xie J., Ma S., Liao W., Zhang J., Luo R., Targeted knock down of CCL22 and CCL17 by siRNA during DC differentiation and maturation affects the recruitment of T subsets Immunobiology 2010 215 2 153 162
43. Park J. M., Terabe M., Donaldson D. D., Forni G., Berzofsky J. A., Natural immunosurveillance against spontaneous, autochthonous breast cancers revealed and enhanced by blockade of IL-13-mediated negative regulation Cancer Immunology, Immunotherapy 2008 57 6 907 912
44. Wild P. J., Kunz-Schughart L. A., Stoehr R., Burger M., Blaszyk H., Simon R., Gasser T., Mihatsch M., Sauter G., Hartmann A., High-throughput tissue microarray analysis of COX2 expression in urinary bladder cancer International Journal of Oncology 2005 27 2 385 391
45. Hung T. T., Wang H., Kingsley E. A., Risbridger G. P., Russell P. J., Molecular profiling of bladder cancer: involvement of the TGF- pathway in bladder cancer progression Cancer Letters 2008 265 1 27 38
46. Arum C. J., Anderssen E., Viset T., Kodama Y., Lundgren S., Chen D., Zhao C. M., Cancer immunoediting from immunosurveillance to tumor escape in microvillus-formed niche: a study of syngeneic orthotopic rat bladder cancer model in comparison with human bladder cancer Neoplasia 2010 12 6 434 442
47. Adam L., Black P. C., Kassouf W., Eve B., McConkey D., Munsell M. F., Benedict W. F., Dinney C. P. N., Adenoviral mediated interferon- 2b gene therapy suppresses the pro-angiogenic effect of vascular endothelial growth factor in superficial bladder cancer Journal of Urology 2007 177 5 1900 1906 (Pubitemid 46560641)
48. Nonaka K., Saio M., Suwa T., Frey A. B., Umemura N., Imai H., Ouyang G. F., Osada S., Balazs M., Adany R., Kawaguchi Y., Yoshida K., Takami T., Skewing the Th cell phenotype toward Th1 alters the maturation of tumor-infiltrating mononuclear phagocytes Journal of Leukocyte Biology 2008 84 3 679 688